A model-based control protocol for transition from ICU to HDU: Robustness analysis.

Area of Science:

• Biomedical Engineering
• Computational Biology
• Endocrinology

Background:

• Continuous glucose monitoring (CGM) and model-based control offer potential for improved diabetes management.
• Traditional glucose control (TGC) protocols can be intensive and burdensome for patients.
• Insulin Glargine is a long-acting basal insulin analog widely used in diabetes therapy.

Purpose of the Study:

• To evaluate the robustness of a model-based control protocol for basal insulin delivery using insulin Glargine.
• To assess the protocol's performance under simulated physiological variability and sensor errors.
• To compare the model-based protocol to less intensive glucose control strategies.

Main Methods:

• In-silico simulation using a Monte Carlo analysis.
• Utilized actual patient data from Christchurch Hospital, New Zealand, to create virtual trial patients.
• Simulated physiological variability (e.g., meal intake, exercise) and sensor inaccuracies.

Main Results:

• The model-based control protocol demonstrated robustness against simulated physiological variability.
• The protocol maintained performance despite the introduction of sensor errors.
• The simulation indicated the model-based approach is a viable less intensive alternative to TGC.

Conclusions:

• Model-based control using insulin Glargine offers a robust and potentially less intensive approach to basal insulin delivery.
• The protocol's resilience to errors suggests its feasibility for real-world diabetes management.
• Further clinical validation is warranted to confirm these in-silico findings.